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gestational administration of prednisone
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Abstract
Background: The teratogenic effects of immunomodulatory and certain antimicrobial therapies are described in
small rodents and humans. While the described teratogenic effects in small rodents have been extrapolated to
make conclusions about its use in the pregnant dam, teratogenic effects of prednisone and doxycycline have not
yet been reported in the dog. Here we report and describe midline defects observed in a litter of golden retriever
puppies exposed to mid-gestational immunosuppressive and antimicrobial therapy.
Case presentation: Twenty-one days into gestation, the dam of a litter of eight golden retriever puppies was
administered prednisone, doxycycline, and tramadol as treatment for immune-mediated polyarthritis. The individuals in
the litter were subsequently diagnosed with a variety of midline defects and congenital cardiac defects. This case series
describes the variety of identified defects and presents a descriptive account of complex congenital abnormalities that
are likely secondary to teratogenic effects of one or more drugs administered during gestation. The available puppies,
dam, and grand dam underwent thorough physical examination, complete echocardiogram, and where indicated,
advanced imaging with various surgical corrections when possible.
Numerous midline congenital defects and congenital heart disease were identified in the puppies evaluated. Ultimately
5 of 8 puppies born to the dam were presented for thorough evaluation. The midline defects include: gastroschisis (1),
peritoneopericardial diaphragmatic hernias (4, PPDH), umbilical hernia (4), unilateral cryptorchidism (1 of 4 males), cleft
palate (1), renal agenesis (1), renal abnormalities (1), sternal and vertebral abnormalities (3), remnant liver lobe (1) and
malformations consistent with ductal plate malformations with congenital hepatic fibrosis (1). The congenital cardiac
defects include: ventricular septal defect (4, VSD) and subaortic stenosis (4, SAS). The presence of greater than one
congenital defect was noted in all 5 of the dogs evaluated. Surgical correction was necessary for PPDH in 4 puppies.
Medical intervention was recommended for congenital cardiac disease in 1 puppy.
Conclusion: This case report is the first to describe midline defects in dogs that have been exposed to
immunomodulatory therapy during gestation. A causative relationship between mid-gestational
immunomodulatory exposure and midline defects cannot be proven, however, this case supports a clear
association and provides case-based evidence to support its avoidance when possible.
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Background
A 6-year-old golden retriever primiparous dam gave
birth to a litter of eight puppies with multiple mid-
line defects (Table 1). The sire had no reported
midline defects or cardiac abnormalities in multiple
previous litters. At 3 weeks gestation, the dam de-
veloped suspect immune-mediated polyarthritis
(IMPA) that resolved following empirical treatment.
Treatment included doxycycline 4.7 mg/kg orally
every 12 h for 30 days, tramadol 3.1 mg/kg orally
every 12 h for an unknown duration, and an im-
munosuppressive dose of prednisone of 0.95 mg/kg
orally every 12 h for 10 days tapered gradually over
20 days. The puppies were carried to term and de-
livered without complications. At the time of birth
8 puppies were delivered. One was born with a gas-
troschisis with a 1 cm abdominal wall defect and a
cleft palate. This puppy was found deceased 12 h
after birth. A second puppy was born with a de-
creased birth weight of 0.22 kg and was found de-
ceased 24 h after birth. No necropsies were
performed. At 15 weeks of age, 4 of the remaining
6 puppies were presented to the Cardiology Service
at the University of California, Davis Veterinary
Medical Teaching Hospital (UCD VMTH) for mur-
mur evaluation (murmur was noted in 1 puppy at a
routine exam). The dam and grandmother of the lit-
ter were evaluated during the same visit and deter-
mined to be clinically normal based on physical
examination and complete echocardiogram evalu-
ation. The following case report describes the clin-
ical outcome in 5 of the puppies. This is the first
case report to describe dogs born with multiple
midline defects after mid-gestational exposure to
prednisone, doxycycline and tramadol.
Case presentation
Dog 1
At 7.5 weeks of age an incidental murmur was detected
as was unilateral cryptorchidism during a routine well-
ness visit. At 8 weeks of age, he was presented to the
Cardiology Service at the UCD VMTH for further evalu-
ation. On physical examination, a grade IV/VI left basilar
systolic ejection murmur, a grade IV/VI right parasternal
systolic harsh murmur, and femoral pulses parvus et tar-
dus were noted. An echocardiogram revealed severe SAS
characterized by a hyperechoic subaortic ridge (Fig. 1)
and left ventricular outflow tract velocity (LVOT Vmax)
of 4.7 m/s. A restrictive, left to right shunting, perimem-
branous ventricular septal defect (VSD) was detected
with a velocity of 4.5 m/s across the defect. No arrhyth-
mias were appreciated on lead II electrocardiogram
(ECG) during the echocardiogram. An agitated saline
intravenous contrast study was performed and no evi-
dence of a right to left shunt was noted. Atenolol was
prescribed with dose increases to maintain a dose of
0.8–0.9 mg/kg q12 as the puppy grew.
Reevaluation at 15 weeks of age revealed progres-
sion in the murmur intensity, and atenolol was dose
escalated to achieve a 1.67 mg/kg q12 dose. During
reevaluation at 20 weeks of age, thoracic radiographs
were performed which revealed marked aortic en-
largement and no obvious skeletal malformations.
Echocardiogram during this visit showed progressive
left ventricular concentric hypertrophy and the LVOT
Vmax remained severely elevated. The previously re-
ported VSD now had a velocity of 3.8 m/s. Occa-
sional single ventricular premature complexes (VPCs)
were noted on ECG during the echocardiogram. Dog
1 remained subclinical at subsequent follow-up exam-
inations. At 39 weeks of age echocardiogram revealed
Table 1 Individual dogs are reported with an “X” denoting their respective congenital defects. For each congenital defect or defect


















1 X X X 3
2 X X X X X X 6
3 X X X X X X X 7
4 X X X X X 5
5 X X X 3
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no new changes. Unilateral cryptorchidism persisted
throughout evaluations. At the time of writing, dog 1
is 3 years old and is reported to have occasional
syncopal events based on a phone conversation with
the owner.
Dog 2
Dog 2 was born with a 1 cm rent in the body wall at the
umbilicus. The rent was surgically corrected immediately
following parturition and revised due to dehiscence. Dog
2 reportedly underwent cardiac arrest while under
general anesthesia during the second surgery and was
successfully resuscitated. At 13 weeks of age, a grade III/
VI left systolic murmur was noted in the record. A
three-view thoracic radiographic study revealed general-
ized cardiomegaly largely characterized by right-sided
enlargement. A complete blood count revealed a low
hematocrit (HCT) of 32.3% (38.3–56.5%), low hemoglobin
of 11.2 g/dL (13.4–20.7 g/dL), low red blood cells of
5.08 M/uL (5.39–8.70), and lymphocytosis of 7069/uL
(1060–4950/uL). A chemistry panel revealed an elevated
alkaline phosphatase (ALP) of 262 u/L (5–160 u/L), hypo-
chloremia of 106 mmol/L (108–119 mmol/L), hyperpho-
sphatemia of 9.7 mg/dL (2.5–6.1 mg/dL), hyponatremia of
141 mmol/L (142–152 mmol/L), hypoglobulinemia of
2.3 g/dL (2.4–4.0 g/dL) and elevated creatine kinase of
284 U/L (10–200 U/L). The values of the erythrogram,
elevated ALP and phosphorus were considered normal
given the puppy’s age. The lymphocytosis may represent
an epinephrine-stress response or underlying chronic in-
flammation. Mild electrolyte abnormalities may be related
to normal variation or the puppy’s lack of appetite.
Dog 2 was first evaluated by the UCD VMTH at
15 weeks of age. The owner reported a history of vomit-
ing and mucoid diarrhea that waxed and waned with no
history of exercise intolerance or decreased level of en-
ergy, appetite, or thirst. On physical examination, a
grade IV/VI left basilar and right apical systolic heart
murmur was detected. The puppy had a regular rhythm
and adequate femoral pulse quality. An umbilical hernia
was observed. No cleft palate or other obvious midline
defects were noted. Echocardiogram was consistent with
a PPDH. Liver and fat were noted within the pericar-
dium. A small hemodynamically insignificant perimem-
branous VSD was visualized with a left to right shunt
velocity of 3.0 m/s. The VSD was suspected to be re-
strictive, but the presence of abdominal contents within
the pericardial sac hindered proper alignment with the
shunt. A hyperechoic subvalvular ridge and mild left
ventricular hypertrophy were identified. A LVOT Vmax
of 2.8 m/s was noted, consistent with mild SAS.
At 19.5 weeks of age, dog 2 was presented to the Soft
Tissue Surgery Service at UCD VMTH for surgical re-
pair of the previously diagnosed PPDH and ovariohyster-
ectomy (OVH). Preoperative bloodwork revealed a mild
eosinophilia of 2210/ uL (70–1490/uL), lymphocytosis of
8840/uL (1060–4950/uL), elevated ALP of 271 u/L (5–
160 u/L) and elevated alanine transferase (ALT) of 126
u/L (18–121 u/L). To evaluate for causes of eosinophilia
and lack of a stress leukogram an ACTH stimulation test
was performed. The results were inconsistent with hypoa-
drenocorticism (pre-cortisol 0.6 μg/dL, post cortisol 9.0
μg/dL). Repeated fecal examinations were also performed
which were consistently negative. Thoracic radiographs
revealed an enlarged cardiac silhouette with a dorsal peri-
toneopericardial mesothelial remnant (DPMR) and lack of
the liver within the abdomen consistent with the diagnosis
of PPDH. Additionally, radiographs revealed aortic dila-
tion likely related to the diagnosis of SAS.
An exploratory laparotomy, corrective herniorrha-
phy, and OVH were performed. The caudal sternebra
was under-developed and bifurcated. The left medial
and quadrate liver lobes were herniated through an
approximately 3 cm defect in the diaphragm into the
pericardial sac. Many adhesions were present. The
spleen was irregular in shape with evidence of
capsular fibrosis. The common bile duct was moder-
ately dilated and the gallbladder could not be identi-
fied or located.
The liver lobes were gently reduced into the abdomen
and the diaphragmatic defect was closed using a bilateral
diaphragmatic rotational flap. An OVH was performed
without complication. Dog 2 recovered from anesthesia
uneventfully.
Due to persistent gastrointestinal signs a focal abdom-
inal ultrasound was performed 2 weeks post-procedure
and a gallbladder could not be identified. This was
consistent with the intraoperative findings. Recheck
echocardiogram at 39 weeks of age revealed static SAS
Fig. 1 Echocardiographic image from the right parasternal long-axis
view of Dog 1. There is a hyperechoic subaortic ridge present (denoted
by arrow) as well as poststenotic dilation of the aorta consistent with
subaortic stenosis (SAS). The left ventricular walls appear thickened
consistent with concentric hypertrophy secondary to the pressure
overload from SAS
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and aneurysmal tissue in the area of the previously re-
ported VSD effectively patching the defect.
By 2 years of age the dog began experiencing seizure
episodes. Chemistry panel revealed an elevated ALT 393
(21–72), increased aspartate aminotransferase AST 70
(20–49), low blood urea nitrogen (BUN) 8 (11–33) and
hypoproteinemia 5.3 (5.4–6.9). Serum bile acid assess-
ment suggested hepatic dysfunction (pre and post values
of 351.6 and 1.8 respectively). Serum ammonia level was
increased [118 μg/dL (0–59)] and an abdominal ultra-
sound revealed evidence of portal hypertension and a
small volume of peritoneal effusion. An extrahepatic or
intrahepatic portosystemic shunt could not be identified
on ultrasound. Three phase computed tomographic im-
aging of the abdomen revealed multiple acquired extra-
hepatic portosystemic shunts likely due to portal
hypertension. A laparoscopic biopsy of the liver revealed
moderate chronic multifocal lobular collapse with portal
to portal bridging fibrosis, arteriolar reduplication, biliary
hyperplasia, reduced portal vein profiles, and oval cell
hyperplasia consistent with ductal plate malformation and
congenital hepatic fibrosis. Acquired extrahepatic porto-
systemic shunts were therefore likely acquired secondary
to fibrosis [1]. Medical management was initiated (amoxi-
cillin 500 mg orally q12h, lactulose 4.5 mls orally q12h,
and omeprazole 20 mg orally q24h). A 3-day course of
tramadol 100 mg orally q8-12 h was initiated for sedation
and pain management following laparoscopic biopsy.
Echocardiogram during this visit revealed no significant
changes.
At the time of writing, dog 2 occasionally develops asci-
tes due to liver disease, which is therapeutically drained.
Dog 3
Evaluation was performed at 15 weeks of age. The
puppy had a history of soft mucoid stool, several epi-
sodes of shallow panting while at rest, and was
calmer than the other littermates. On physical exam-
ination, a 2 cm, non-reducible umbilical hernia was
noted. No cardiac structural or functional abnormal-
ities were identified on echocardiogram, however a
PPDH was observed with liver identified within the
pericardial sac that limited the cardiac examination
(Fig. 2).
A CBC and chemistry panel performed at 19 weeks
of age were unremarkable. A follow-up echocardio-
gram performed at this time revealed a small peri-
membranous VSD sealed by aneurysmal tissue and
high normal aortic outflow velocity of 1.98 m/s rais-
ing concern for equivocal or mild SAS in a puppy of
this age. Thoracic radiographs were consistent with a
PPDH. Only 7 sternebrae segments were present. An
exploratory laparotomy, herniorrhaphy, cranioventral
abdominal wall defect repair, and castration were
performed. Intra-operatively, the surgeon noted the
appearance of the caudal sternebrae to be subjectively
abnormal and xiphoid process remained cartilaginous
and underdeveloped in appearance. A portion of the
right medial liver lobe and gallbladder were herniated
into the pericardial sac. The herniation was through
an approximately 4–6 cm defect in the diaphragm
into the pericardium (Fig. 3). The quadrate liver lobe
was hypoplastic. Left renal agenesis was also noted,
although the left adrenal was present. The herniated
liver lobe and gallbladder were reduced manually into
the abdomen and the defect was closed using a bilat-
eral diaphragmatic rotational flap.
Fig. 2 Right parasternal echocardiographic image of Dog 3. There is
a small volume of hypoechoic pericardial effusion (denoted by
asterisk) and soft tissue structure most consistent with liver (labeled
as L) within the pericardial space, adjacent to the heart (left ventricle
labeled as LV)
Fig. 3 Image from the laparotomy performed on Dog 3. There is a
4x6cm defect through the central tendon of the diaphragm that
communicates with the pericardial sac, consistent with a
peritoneopericardial diaphragmatic hernia. A portion of the right
medial liver lobe can be seen herniated into the pericardial sac
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During a follow-up examination at 22 weeks of age,
the owner reported that dog 3 was doing excellent at
home with an improved level of energy and no vomiting
or diarrhea. At the time of writing, dog 3 is alive and
apparently healthy based on a phone conversation with
the owner.
Dog 4
During the initial evaluation at 15 weeks of age, Dog 4
was reported asymptomatic. On physical examination an
umbilical hernia was present and gut sounds auscultated
in the thorax. No heart murmur was noted. An echocar-
diogram was performed, revealing a PPDH consisting of
dilated air-filled small intestinal loops within the pericar-
dial sac. No functional or structural cardiac abnormal-
ities were identified. However, cardiac evaluation was
limited due to acoustic artifact from air present within
the pericardial space.
At 19 weeks of age, pre-operative bloodwork was per-
formed which revealed a mild leukocytosis of 18.2 K/uL
(4.9–17.6 K/uL) characterized by a lymphocytosis of
8245/uL (1060–4950/uL), hyperphosphatemia 9.0 mg/dL
(2.5–6.1 mg/dL), and a slightly elevated creatine kinase
208 U/L (10–200 U/L). Thoracic radiographs were con-
sistent with a PPDH with suspect herniation of intestinal
loops and liver (Fig. 4). A repeat echocardiogram per-
formed the day before surgical repair revealed a small,
restrictive, perimembranous VSD with left to right
shunting and mild tricuspid valve regurgitation. An
exploratory laparotomy, herniorrhaphy, umbilical hernia
repair, and castration were performed. Upon exploratory
laparotomy, there was an additional pinpoint 2 mm defect
present in the cranial abdominal wall on midline near the
umbilicus, and a 4 cm defect in the diaphragm communi-
cating with the pericardial sac (Fig. 4). The xiphoid region
was subjectively abnormal and the transversus thoracicus
was noted to be more caudal than normal with midline
asymmetry. The right-sided muscle was displaced caudal
compared to the left. Abdominal contents found herniated
into the pericardial sac included duodenum, the majority
of the jejunum, half of the left lateral liver lobe, half of the
left medial liver lobe, gallbladder, quadrate lobe, and a por-
tion of the right medial liver lobe. The right kidney was
observed to be smaller than the left kidney. An incidental
cloth foreign body was palpated in the jejunum and conse-
quentially removed by conventional simple enterotomy as
previously described [2]. After abdominal organs were re-
duced back into the abdominal cavity, excess pericardium
was excised and the pericardial sac was closed. The edges
of the diaphragmatic defect were closed with bilateral dia-
phragmatic rotational flaps. The umbilical defect was
repaired during closure of the abdominal incision. Castra-
tion was performed without complication.
Three weeks post-procedure (at 22 weeks of age)
Dog 4 was evaluated for inappetence. On physical
examination he was hyperthermic (rectal temperature
103.5 degrees Fahrenheit), tachypneic, and tachycar-
dic. A chemistry panel revealed hypoglycemia 63 mg/
dL (77–150 mg/dL) and 1.5 mls of 50% dextrose was
administered orally. An automated CBC revealed a
marked leukocytosis of 31.98 K/uL (5.05–16.76 K/uL)
characterized by a neutrophilia of 27.83 K/uL
(2.95011.64 K/uL) and a suspected left shift. Full body
radiographs were suspicious for marked gastroenter-
itis. A parvovirus SNAP test was negative. Dog 4 was
referred to the UCD VMTH for further care. A
second parvovirus SNAP test and parvovirus PCR test
were performed. Both were positive for parvovirus
infection. The puppy was treated with aggressive sup-
portive care and he recovered fully.
At the time of writing, dog 4 is alive and apparently
healthy based on a phone conversation with the owner.
Fig. 4 Right lateral (a) and dorsoventral (b) thoracic radiographs from Dog 4. The cardiac silhouette is markedly enlarged and rounded and there
are visible intestinal loops containing granular and soft tissue opaque material superimposed on the ventral cardiac silhouette. There is border
effacement of the ventral margin of the diaphragm, and the intestinal loops superimposed on the cardiac silhouette are confluent with the
abdomen. These findings are consistent with a peritoneopericardial diaphragmatic hernia with suspect herniation of intestinal loops and
potentially liver
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Dog 5
Dog 5 was first evaluated by the UCD VMTH at 22 weeks
of age. A physical examination revealed borborygmi that
were auscultated in the thorax, a 1.5 cm umbilical hernia,
and linguoverted mandibular canines. A complete blood
count and chemistry panel were normal for a puppy
[HCT of 37.5% (40–55), elevated phosphorus 7.8 (2.6–
5.2), total calcium 11.8 (9.6–11.2), and ALP 187 (14–91)]
with the exception of a mildly elevated ALT 81 (21–72). A
urinalysis was unremarkable (USG 1.051 and pH of 6). An
echocardiogram revealed a PPDH and mild SAS, but the
heart was difficult to evaluate due to the presence of
bowel loops within his pericardium. An exploratory lapar-
otomy, herniorrhaphy, and castration were performed.
There was a 3 cm defect in the ventral aspect of the mus-
cular portion of the diaphragm, which communicated
with the pericardium. The small intestine, cecum, colon,
and liver were within the pericardial sac. These organs
were reduced into the abdomen and the defect was closed
in a simple continuous appositional fashion. Castration
was performed without complication. Dog 5 recovered
uneventfully from anesthesia. Prior to surgery, dog 5 had
vomited up a pair of socks, but no other foreign objects
were found during surgery. No recheck echocardiographic
data is available.
At the time of writing, dog 5 is alive and apparently
healthy according to owner during a phone conversation.
Dam & Grand Dam
The dam and grand dam were evaluated by the UCD
VMTH Cardiology Service during the litter’s initial visit.
Both the dam and grand dam had normal heart struc-
ture and function on echocardiogram with an LVOT
Vmax’s of 1.83 m/s and 1.87 m/s, respectively. Fractional
shortening was 30 and 33%, respectively. No midline de-
fects or cardiac shunts were identified.
The remaining live puppy of the litter was unavailable
for evaluation by the UCD VMTH Cardiology Service.
Discussion and conclusions
In this case series, the dam developed a presumed
gestational IMPA, which prompted treatment with
prednisone, doxycycline, and tramadol. The resulting
litter of puppies developed multiple midline defects.
The prescribed treatment and resultant defects appear
correlated, however it is impossible to determine if
these results are specifically due to the drug adminis-
tration, the dam’s immune-mediated disease, heredi-
tary effects, genetic susceptibility, epigenetics, or
another unidentified cause. In addition because 3
drugs were given it cannot be determined if the mid-
line defects were due to the prednisone, doxycycline,
tramadol, or an effect of the three drugs administered
concomitantly. The inability to control these multiple
variables is one of the major limitations of this case
series. However, ethical considerations make it impos-
sible to design a prospective canine study in which
these variables can be controlled. The null hypothesis
that the litter of puppies developed congenital disease
unrelated to any environmental factors must be con-
sidered. However, the number and variety of defects
affecting all puppies is less typical of a genetic muta-
tion and more characteristic of a teratogen.
The midline defects observed included a cleft palate,
gastroschisis, umbilical hernias, a large abdominal her-
nia, ventricular septal defects, cryptorchidism, malfor-
mation of the xiphoid and transversus thoracicus, spina
bifida, renal dysplasia, renal agenesis, hypoplastic liver
lobe, malformations consistent with ductal plate malfor-
mations and congenital hepatic fibrosis, and PPDHs.
Other congenital cardiac defects noted included SAS. A
review by Evans and Biery described the history, clinical
signs, radiographic and surgical findings in 13 dogs with
PPDHs [3]. Concurrent umbilical hernias were noted in
4 dogs, congenital cardiac disease in 2 dogs, and sternal
deformities in 6 dogs. Surgical correction was successful
in 9 of the 11 dogs examined and clinical signs remained
only in 2 dogs. The review reported that the organs most
frequently herniated into the pericardial sac include the
gallbladder and liver lobes. Small intestinal loops, stom-
ach and spleen were less commonly herniated into the
pericardial sac. Mesentery, omentum, and the falciform
ligament were rarely observed in the pericardial sac.
These findings were consistent with the defects identi-
fied in this case series. Unlike the current case series,
there was no history of reported disease or drug admin-
istration in the dams during pregnancy.
Two of the dogs in this case series had sternal abnor-
malities which is commonly reported in dogs with
PPDH. While, the time period of sternal ossification
specifically in the dog has not been well-described, one
report in the cat describes sternal ossification occurring
on days 28–32 of gestation [4, 5]. At the time of PPDH
correction surgery in one of the dogs, the xiphoid
process remained cartilagenous, suggesting a failure of
ossification.
Subaortic stenosis was identified in 4 of the dogs eval-
uated. SAS is overrepresented in the golden retriever
and has been demonstrated to be familial, making up ap-
proximately 15% of cases [6]. Thus it should be consid-
ered that development of SAS in these puppies may be
unrelated to the other defects. However, the concurrent
finding of a VSD in all the puppies may suggest that at
least a component of their congenital heart disease was
indeed due to teratogenic exposure. While multiple con-
genital malformations have been reported with SAS, in-
cluding VSDs, in previous studies, it is unknown if these
dogs had additional midline defects unrelated to the
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heart as the clinical history and presentation of these
dogs was not reported [6, 7]. It is interesting to note that
the dam and grand dam did not have any evidence of
subaortic stenosis. However, a cardiology examination
was not performed on the sire.
It is important to recognize that the total tabulation of
defects may be incomplete. In addition to having one
dog without complete evaluation, one of the puppies did
not have a peritoneopericardial diaphragmatic hernia
and so an abdominal ultrasound and/or an exploratory
laparotomy were not performed. There could have been
other midline defects present in these 2 puppies that
went unrecognized. The sire of the litter could not be
evaluated. Therefore, it is unknown if any congenital de-
fects detected in this litter were related to undetected
hereditary diseases that may have been vertically trans-
mitted from the sire, or current diseases or drug admin-
istration during conception. Although the sire was
reported to produce multiple prior litters without any
noted congenital defects, a full physical examination,
echocardiogram, and abdominal ultrasound would be re-
quired to further characterize the health of the sire.
While a direct correlation cannot be made between
the midline defects and the gestational administration of
doxycycline, prednisone, and tramadol, the overwhelm-
ing number of defects in this litter should serve as a sig-
nificant warning against at minimum the concomitant
use of these medications during gestation. This is the
first report in the dog of congenital defects associated
with simultaneous gestational administration of prednis-
one, doxycycline, and tramadol. While it is generally rec-
ommended to avoid drug administration during
pregnancy, there are certain circumstances in which
their use must be considered [8]. The Food and Drug
Administration (FDA) has made recommendations for
human, canine, and feline drug administration based on
the organization’s highest level of knowledge. Ideally,
safety information about drug administration during
pregnancy is based on randomized prospective studies in
the specific species of interest. However, for ethical rea-
sons, the reported safety of many drugs for human, fe-
line, and canine medicine are often based on data
extrapolated from laboratory rodents and mice rather
than the direct species receiving the medication. This
limits our level of confidence in the safety of medica-
tions we use during pregnancy and potential adverse ef-
fects on the fetus and dam.
In the current study, drug exposure occurred during
the dam’s third week of gestation. This period of gesta-
tion is during the transition from stage 1 to stage 2 of
pregnancy in which embryo implantation and fetal ossi-
fication occur [9]. Because this is a period of rapid fetal
growth and development, exposure to exogenous drugs
or chemicals at this time may cause skeletal, organ, limb,
or neurologic abnormalities. In addition, the prednisone
and the doxycycline were continued for a course of
30 days, resulting in this drug exposure from roughly
week 3 to week 8 of total gestation time. The duration
of tramadol administration was unknown. The most re-
cent information reported regarding reproductive
safety of doxycycline and prednisolone in the veterin-
ary literature dates back to 1989 [10] and the terato-
genic effects of doxycycline, prednisolone, and
tramadol have not been reported in veterinary pa-
tients outside of the laboratory setting. Due to the
paucity of information in the veterinary field, add-
itional recommendations are based on the FDA’s
guidelines in human medicine, rather than specific
studies or case reports observed in the dog [9].
Tramadol is listed by the FDA as a pregnancy category
C drug, indicating that while animal studies show ad-
verse effects to the fetus, there were no studies that
demonstrate these adverse effects in humans or specific
animal species that the drug is labeled for. In laboratory
animals, embryotoxicity and fetotoxicity was observed
only at 3–15 times the recommended dose [11]. No
teratogenic effects were observed at therapeutic doses or
at doses that did not cause toxicity in the mother. A
2015 retrospective study in human medicine evaluated
the outcome of offspring in pregnant women who re-
ceived tramadol. There was weak positive correlation be-
tween the incidence of congenital cardiac defects in
offspring and women who received tramadol while preg-
nant, exposing the teratogenic potential of tramadol.
While causation cannot be concluded from this study,
this finding indicates that we cannot rule out the poten-
tial for tramadol to cause teratogenic effects in mamma-
lian species, including the dogs in this case series [12].
Doxycycline is listed by the FDA as a pregnancy cat-
egory D drug, which indicates that there is evidence of
fetal risk in animals and humans, and the drug is only
indicated if needed for life-threatening or serious dis-
ease. According to a review article by Papich, doxycyc-
line is defined as a class D drug in a separate categorical
system, meaning its use is contraindicated in the preg-
nant dog because this drug has been shown to cause
congenital malformations or embryotoxicity [8]. Tetracy-
clines have been associated with skeletal and teeth
malformations, as well as teeth discoloration in the fetus
[8]. While tetracyclines are considered teratogens, a
study by Czeizel et al. looked specifically at doxycycline
and its teratogenic potential [13, 14]. This case-control
paired analysis revealed a statistically significant differ-
ence between the number of pregnant women treated
with doxycycline who had infants with no birth defects
[63 out of 32,804 (0.19%)] and number of pregnant
women treated with doxycycline who had infants with
birth defects [56 out of 18,515 (0.30%)]. However, this
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study did not show a statistically significant higher rate
of congenital abnormalities with doxycycline treatment
given during the second and third months of gestation.
Prednisone is reported as a class C drug for use in dogs
and cats, meaning these drugs have potential risks and
should only be used when the benefit of therapy clearly
outweighs the risks [15]. Like tramadol, The FDA has also
listed it a category C drug. More recently, corticosteroids
have been changed to a category D drug in humans due to
recent data suggesting that corticosteroids administered
during the first trimester in animals and humans cause an
increased risk for oral cleft palate formation, intrauterine
growth restriction, and decreased birth weight [1, 14–17].
Board et al. describe a case in which a pregnant woman
receiving a renal transplant with concurrent prednisone
and azathioprine therapy had no evidence of teratogenic
effects on the fetus [18]. Another case report described a
pregnant woman with chronic liver disease that was
treated with azathioprine and prednisone in whom no
teratogenic effects were observed [19]. While these case
reports do not support the teratogenic potential of pred-
nisone, a report by Bongiovanni and McPadden observed
that large doses of corticosteroid administration can lead
to fetal resorption and decreased fetal size and viability
[20]. Out of 260 pregnancies treated with cortisone or an
analogue, they reported 8 stillborn infants, 1 abortion, and
15 premature infants; seven full-term infants were re-
ported to show various disorders [20]. Only 2 infants in
the study showed cleft palates and in both cases, steroids
were administered prior to the fourteenth week of preg-
nancy at high doses. Similar data is observed in laboratory
rodents. In one report pregnant mice treated with corti-
sone develop offspring with a cleft palate, with the highest
incidence of cleft palates being between the tenth and
eleventh days of gestation out of 19 days total [16, 17].
Notably teratogenicity of cortisone depended on the dose,
time during gestation, and genetic strain of mice. Other
defects reported include shortening of the head, mandible,
spina bifida, and marked reduction in birth weight. It is in-
teresting to note that the control group in this study had
no incidence of cleft palates.
It is difficult to extrapolate data seen in laboratory ani-
mals because laboratory animal strains may have a higher
number of steroid receptors compared to dogs and cats
[15]. Nevertheless, the FDA advises to use prednisone dur-
ing pregnancy with caution in all animal species. If anti-
inflammatory or immunosuppressive therapy is necessary,
prednisone is the preferred choice because it is relatively
short-acting compared to longer acting corticosteroids,
such as dexamethasone. This case series does not serve to
change the guidelines for the use of prednisone in the
pregnant dam, but to expose a knowledge gap in the safety
data available for use of doxycycline and prednisone in the
pregnant dog. In human medicine, pregnancy exposure
registries are used to gather data about how prescription
drugs affect pregnant women and their fetus. This model
may serve useful in veterinary medicine to develop a
stronger understanding of the teratogenic potential of
prednisone, doxycycline, and tramadol. In the absence of
extensive exposure registries for companion animals, case
series such as this should serve as a clinical warning for
the possible consequences of gestational drug use.
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